Technical Analysis for ARVN - Arvinas, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 200 DMA | Bullish | 0.00% | |
Expansion Breakout | Bullish Swing Setup | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Volume Surge | Other | 0.00% | |
Wide Range Bar | Range Expansion | 0.00% | |
Parabolic Rise | Strength | 0.00% | |
Multiple of Ten Bullish | Other | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Above Upper BB | Strength | 0.00% | |
Gapped Up | Strength | 0.00% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Possible Pocket Pivot | about 18 hours ago |
60 Minute Opening Range Breakout | about 21 hours ago |
Rose Above Upper Bollinger Band | about 22 hours ago |
2x Volume Pace | about 22 hours ago |
1.5x Volume Pace | about 22 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/06/2023
Arvinas Inc. is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas uses its proprietary technology platform to engineer proteolysis targeting chimeras, or PROTAC™ protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Disease Genetics Proprietary Technology Metabolism Chimera
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Disease Genetics Proprietary Technology Metabolism Chimera
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 39.31 |
52 Week Low | 13.57 |
Average Volume | 642,363 |
200-Day Moving Average | 24.21 |
50-Day Moving Average | 18.79 |
20-Day Moving Average | 21.38 |
10-Day Moving Average | 23.99 |
Average True Range | 2.08 |
RSI (14) | 74.09 |
ADX | 32.87 |
+DI | 47.72 |
-DI | 17.09 |
Chandelier Exit (Long, 3 ATRs) | 24.72 |
Chandelier Exit (Short, 3 ATRs) | 20.29 |
Upper Bollinger Bands | 28.54 |
Lower Bollinger Band | 14.22 |
Percent B (%b) | 1.12 |
BandWidth | 66.99 |
MACD Line | 2.13 |
MACD Signal Line | 1.51 |
MACD Histogram | 0.6183 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 40.33 | ||||
Resistance 3 (R3) | 39.44 | 35.20 | 38.66 | ||
Resistance 2 (R2) | 35.20 | 32.65 | 35.65 | 38.10 | |
Resistance 1 (R1) | 32.75 | 31.07 | 33.98 | 33.64 | 37.54 |
Pivot Point | 28.52 | 28.52 | 29.13 | 28.96 | 28.52 |
Support 1 (S1) | 26.07 | 25.96 | 27.29 | 26.96 | 23.06 |
Support 2 (S2) | 21.83 | 24.39 | 22.28 | 22.50 | |
Support 3 (S3) | 19.38 | 21.83 | 21.94 | ||
Support 4 (S4) | 20.27 |